Neurosalience develops a tool for the early detection of dementia from MRI scans. The tool allows private healthcare companies to decrease patient-related costs and improve the quality of life of their clients. The product is capable of processing even low-resolution MRI data from older scanners with potential extensions to CT scans which are cheap and widely available.
Medical, mHealth, Therapeutics, Health Care
No funding announced yet
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as Neurosalience? We’re happy to assist you with our Startup Sourcing service.